I am also curious about this. One publication shows an EF-1a promoter plasmid which should be active in mESCs. CBh looks similar to the chicken actin-CMV hybrid (pCAG) which is highly active in ESCs, but I would certainly be curious to know if anyone has used the CBh-Cas9 plasmid in mouse ESCs.
--
You received this message because you are subscribed to the Google Groups "Genome Engineering using CRISPR/Cas Systems" group.
To unsubscribe from this group and stop receiving emails from it, send an email to crispr+un...@googlegroups.com.
For more options, visit https://groups.google.com/groups/opt_out.
You received this message because you are subscribed to a topic in the Google Groups "Genome Engineering using CRISPR/Cas Systems" group.
To unsubscribe from this topic, visit https://groups.google.com/d/topic/crispr/zv3W8lFwEpg/unsubscribe.
To unsubscribe from this group and all its topics, send an email to crispr+un...@googlegroups.com.
For more options, visit https://groups.google.com/d/optout.
hesc (Hues 9) culture and transfection ● tIMInG 3–4 d
crItIcal hESCs and human induced pluripotent stem cells can vary widely in their transfection efficiency, tolerance of
single-cell dissociation and maintenance conditions. For a given cell line of interest, relevant literature or the distributor
should be consulted.
30| Maintaining HUES9 cells. We routinely maintain HUES9 cells (a hESC cell line) in feeder-free conditions with mTesR1 medium. Prepare mTeSR1 medium by adding the 5× supplement included with the basal medium and 100 μg ml−1 Normocin.
31| Prepare a 10-ml aliquot of mTeSR1 medium supplemented further with 10 μM ROCK inhibitor.
32| Coating a tissue culture plate. Dilute cold GelTrex 1:100 in cold DMEM and coat the entire surface of a 100-mm tissue
culture plate.
33| Place the plate in an incubator for at least 30 min at 37 °C.
34| Thaw a vial of cells at 37 °C, transfer the cells to a 15-ml Falcon tube, add 5 ml of mTeSR1 medium and pellet at 200g for 5 min at room temperature.
protocol
35| Aspirate the GelTrex coating (Step 32) and seed ~1 × 106 cells with 10 ml of mTeSR1 medium containing ROCK inhibitor from Step 31.
36| Replace with mTeSR1 medium without ROCK inhibitor after 24 h and refeed daily.
37| Passaging cells. Passage the cells before they reach 70% confluency.
38| Aspirate the mTeSR1 medium and wash the cells once with DPBS.
39| Dissociate the cells by adding 2 ml of Accutase and incubating them at 37 °C for 3–5 min.
40| Add 10 ml of mTeSR1 medium to the detached cells, transfer the mixture to a 15-ml Falcon tube and resuspend gently.
41| Replate the cells onto GelTrex-coated plates in mTeSR1 medium with 10 μM ROCK inhibitor.
42| Replace with normal mTeSR1 medium 24 h after plating.
43| Transfection. We recommend culturing cells for at least 1 week after thawing and before transfecting by using the Amaxa
P3 primary cell 4D Nucleofector kit.
44| Refeed log-phase growing cells (50–70% confluency) with fresh medium 2 h before transfection.
45| Dissociate to single cells or small clusters of no more than ten cells (as viewed under the microscope) with Accutase and gentle resuspension.
46| Count the number of cells needed for nucleofection (200,000 cells per transfection) and spin down at 200g for 5 min at room temperature.
47| Remove the medium completely and resuspend it in 20 μl of S1-supplemented P3 nucleofection solution, per 2 × 105 cells. 48| Pipette the resuspended cells with added DNA (Steps 9 and 19) into electroporation cuvettes and electroporate
according to the suggested program. For 2 × 105 cells, we typically use 1 μg of total DNA.
49| Gently plate the electroporated cells onto coated 100-mm plates supplemented with 10 μM ROCK inhibitor.
Thanks a lot, Ann.
Following are some words from a student's thesis, I'm confused who is right.
iPSCs are a very difficult cell type to experiment with and choosing the optimal iPSC promoter is no exception. The original Cas9 plasmid contains only a Chicken β-Actin Promoter (pCBh). This promoter has been shown to express proteins only in normal cell types (i.e. HEK293t cells) but will not drive expression of proteins within hESCs or iPSCs. A suitable replacement for the pCBh promoter is a CAG promoter. The CAG promoter consists of three genetic components that will help drive expression of proteins within a hESC. Its components include a Cytomegalovirus (CMV) enhancer, a Chicken-β-actin promoter, and a Rabbit β-Globulin Splice acceptor gene. Previous studies have shown that the stronger CAG promoter will help promote expression of transgenic genes within hESCs (Chen et. al., 2011).
There are many labs using the pSpCas9-(BB)-2A-Puro(Px459) plasmid. They want to select the cells which can be resistant to puromycin. But after adding puromycin, even at 0.3ug/ml(you use 0.5ug/ml), 24hours later, all of the cells will die. It seems that the Cas9-Puro cannot be expressed at all. Yeah, maybe you will say that they are not careful enough, but I don't think so.
Best,
Ming
...
--
Hi everybody,
we tried to transfect, by amaxa 4D, the PX458 plasmid into human ESC and we have only 15-20% of GFP expression 24h post transfection.
I think Cbh promoter is not the best choice for this cell type.
Feng, have you test differents promoters in the same backbone to compare GFP expression in hESC ?
Have you planned to do a new version of PX458 and PX459 with "hESC promoter" ?
--
You received this message because you are subscribed to the Google Groups "Genome Engineering using CRISPR/Cas Systems" group.
To unsubscribe from this group and stop receiving emails from it, send an email to crispr+un...@googlegroups.com.
To post to this group, send email to cri...@googlegroups.com.
For more options, visit https://groups.google.com/d/optout.